Product Information

IBUPROFEN 600 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0461 per EA under NDC 65162046550. Its NADAC has been published 452 times since Feb 28, 2018.

FDA first approved this application on Jun 18, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 600 MG TABLET

Ibuprofen
$0.0461per EA

Strength

600 mg/1

NDC

65162046550

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078558

FDA Approved

6/18/2007

TE Code

AB

On Market Since

11/23/2009

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 600 MG TABLET has been published 452 times since Feb 28, 2018, and over the history we have for it it has declined 2.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0461 per EA
All-time high$0.0687 (Mar 11, 2020)
All-time low$0.0418 (Jun 20, 2018)
52-week high$0.0472
52-week low$0.0428
Median price$0.0555
Average price$0.0547
Largest weekly change+21.4% (Aug 21, 2024)
Weeks tracked452
Tracking sinceFeb 28, 2018

Price History

1W

0.0%

1M

-2.4%

3M

-1.0%

6M

+4.1%

1Y

-1.6%

3Y

-13.9%

5Y

-23.5%

All

-2.8%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IBUPROFEN 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 600 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.0461 per EA (NDC 65162046550), effective Nov 11, 2026.

How has the price of IBUPROFEN 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 600 MG TABLET has declined 2.8%. It has been tracked across 452 weekly CMS publications since Feb 28, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 600 MG TABLET?

Since Feb 28, 2018, the NADAC for IBUPROFEN 600 MG TABLET has ranged from a low of $0.0418 (Jun 20, 2018) to a high of $0.0687 (Mar 11, 2020), with a median of $0.0555 per EA.

Are there cheaper alternatives to IBUPROFEN 600 MG TABLET?

Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 600 MG TABLET, is $0.0443 per EA — about 4% below IBUPROFEN 600 MG TABLET.

Who manufactures IBUPROFEN 600 MG TABLET?

IBUPROFEN 600 MG TABLET (NDC 65162046550) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.